Literature DB >> 11958927

Current status of immune mechanisms of killing of intracellular microorganisms.

Nahed Ismail1, Juan P Olano, Hui-Min Feng, David H Walker.   

Abstract

The interaction between intracellular pathogens and the mammalian host follows different pathways that reflect evolved survival mechanisms of both the pathogen and the host to assure each one's own survival. From the host's perspective, different immune mechanisms predominate at different stages of infection. Both phagocytic and non-phagocytic target cells participate in microbial uptake and, in some cases, intracellular destruction. In addition, the development of specific immunity ensures sustained activation of intracellular microbicidal mechanisms in the target cells, and induction of apoptotic or lytic target cell death by cytotoxic T lymphocytes. From the pathogen's perspective, different evasion strategies are employed to counteract host defenses. Understanding microbial survival strategies and the immune mechanisms that result in killing of intracellular pathogens will deepen our insight into the pathogenesis of infection that could be applied towards the development of effective vaccination and immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11958927     DOI: 10.1111/j.1574-6968.2002.tb11038.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  26 in total

1.  Persisting Rickettsia typhi Causes Fatal Central Nervous System Inflammation.

Authors:  Anke Osterloh; Stefanie Papp; Kristin Moderzynski; Svenja Kuehl; Ulricke Richardt; Bernhard Fleischer
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

2.  BAY 41-2272, a soluble guanylate cyclase agonist, activates human mononuclear phagocytes.

Authors:  P V Soeiro-Pereira; A Falcai; C A Kubo; E B Oliveira-Júnior; O C Marques; E Antunes; A Condino-Neto
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

3.  Differential interaction of dendritic cells with Rickettsia conorii: impact on host susceptibility to murine spotted fever rickettsiosis.

Authors:  Rong Fang; Nahed Ismail; Lynn Soong; Vsevolod L Popov; Ted Whitworth; Donald H Bouyer; David H Walker
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

4.  OsmC proteins of Mycobacterium tuberculosis and Mycobacterium smegmatis protect against organic hydroperoxide stress.

Authors:  Sankaralingam Saikolappan; Kishore Das; Smitha J Sasindran; Chinnaswamy Jagannath; Subramanian Dhandayuthapani
Journal:  Tuberculosis (Edinb)       Date:  2011-11-15       Impact factor: 3.131

5.  Type I interferon contributes to noncanonical inflammasome activation, mediates immunopathology, and impairs protective immunity during fatal infection with lipopolysaccharide-negative ehrlichiae.

Authors:  Qin Yang; Heather L Stevenson; Melanie J Scott; Nahed Ismail
Journal:  Am J Pathol       Date:  2014-12-04       Impact factor: 4.307

6.  Toxoplasma gondii: immune response and protective efficacy induced by ROP16/GRA7 multicomponent DNA vaccine with a genetic adjuvant B7-2.

Authors:  Qi Liu; Fuwu Wang; Guan Wang; Qunli Zhao; Juan Min; Shuai Wang; Hua Cong; Ying Li; Shenyi He; Huaiyu Zhou
Journal:  Hum Vaccin Immunother       Date:  2013-10-07       Impact factor: 3.452

7.  Survival, replication, and antibody susceptibility of Ehrlichia chaffeensis outside of host cells.

Authors:  Julia Shu-Yi Li; Gary M Winslow
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

Review 8.  Macrophage-targeted photodynamic therapy.

Authors:  T N Demidova; M R Hamblin
Journal:  Int J Immunopathol Pharmacol       Date:  2004 May-Aug       Impact factor: 3.219

9.  Study on myeloperoxidase role in antituberculous defense in the context of cytokine activation.

Authors:  M Koziol-Montewka; A Kolodziejek; J Oles
Journal:  Inflammation       Date:  2004-04       Impact factor: 4.092

10.  Methionine sulfoxide reductase A (MsrA) deficiency affects the survival of Mycobacterium smegmatis within macrophages.

Authors:  T Douglas; D S Daniel; B K Parida; C Jagannath; S Dhandayuthapani
Journal:  J Bacteriol       Date:  2004-06       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.